<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2529-850X</journal-id>
<journal-title><![CDATA[Journal of Negative and No Positive Results]]></journal-title>
<abbrev-journal-title><![CDATA[JONNPR]]></abbrev-journal-title>
<issn>2529-850X</issn>
<publisher>
<publisher-name><![CDATA[Research and Science S.L.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2529-850X2020001000010</article-id>
<article-id pub-id-type="doi">10.19230/jonnpr.3863</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Enfermedad Pulmonar Obstructiva Crónica y comorbilidad]]></article-title>
<article-title xml:lang="en"><![CDATA[Chronic obstructive pulmonary disease and comorbidity]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vázquez Rosa]]></surname>
<given-names><![CDATA[Ana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tarraga Marcos]]></surname>
<given-names><![CDATA[Almudena]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tarraga Marcos]]></surname>
<given-names><![CDATA[Loreto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Romero de Ávila]]></surname>
<given-names><![CDATA[Mario]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tárraga López]]></surname>
<given-names><![CDATA[Pedro-J.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Castilla la Mancha  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Clinico Zaragoza  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,FEA Pediatría de Almansa  ]]></institution>
<addr-line><![CDATA[Albacete ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad Castilla la Mancha  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<volume>5</volume>
<numero>10</numero>
<fpage>1195</fpage>
<lpage>1220</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S2529-850X2020001000010&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S2529-850X2020001000010&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S2529-850X2020001000010&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción.  La enfermedad pulmonar obstructiva crónica (EPOC) es una de las patologías que mayores tasas de prevalencia y mortalidad presenta a nivel mundial, en España representa la 3ª causa de muerte. El tabaco es su principal causa, por lo que es una enfermedad prevenible. Se define como un síndrome complejo y heterogéneo que condiciona tanto calidad de vida como envejecimiento de los que la padecen, especialmente en las últimas décadas de la vida ya que se acompaña de un número de comorbilidades que agravan la propia evolución de la enfermedad.  Objetivos.  Conocer las comorbilidades más prevalentes en la EPOC, así como su relación y posible influencia en el progreso de esta.  Material y métodos.  Búsqueda bibliográfica en Pubmed y Crochrane haciendo uso de los términos "chronic obstructive pulmonary disease" AND "comorbidities", aplicando diferentes filtros durante la misma.  Resultados.  La presencia de comorbilidad en los pacientes con EPOC afecta a la mortalidad a largo y corto plazo. Según la bibliografía resultante la relación existente entre comorbilidad y EPOC puede explicarse por la existencia de inflamación sistémica.  Discusión.  Hay evidencias suficientes para afirmar que la presencia de comorbilidad es un hecho desfavorable en cuanto a evolución del paciente con EPOC.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction.  Chronic obstructive pulmonary disease (COPD) is one of the diseases with the highest prevalence and mortality rates worldwide. In Spain, it is the third leading cause of death. Tobacco is its main risk factor, so it is a preventable disease. We can define it as a complex and heterogeneous syndrome that conditions both quality of life and the aging of those who suffer from it, especially in the last decades of life, since it is accompanied by a not inconsiderable number of comorbidities that aggravate the evolution of the it.  Objectives.  To understand the most prevalent comorbidities in COPD, as well as their relationship and possible influence on the progress of the disease.  Material and methods.  Bibliographic search in Pubmed and Cochrane using the terms "chronic obstructive pulmonary disease" AND "comorbidities", applying different filters during the search. Results: The presence of comorbidity affects short and long term mortality. The relationship between comorbidity and COPD can be explained by the existence of systemic inflammation.  Discussion.  There is enough evidence to affirm that the presence of comorbidity is an unfavourable fact in terms of the evolution of the patient with COPD.  Conclusions.  A multidimensional assessment of the COPD patient is necessary, as well as comprehensive and individualized care.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[enfermedad pulmonar obstructiva crónica]]></kwd>
<kwd lng="es"><![CDATA[Comorbilidades]]></kwd>
<kwd lng="es"><![CDATA[tratamientos]]></kwd>
<kwd lng="en"><![CDATA[chronic obstructive pulmonary disease]]></kwd>
<kwd lng="en"><![CDATA[Comorbidities]]></kwd>
<kwd lng="en"><![CDATA[treatments]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="">
<collab>OMS</collab>
<source><![CDATA[Enfermedad pulmonar obstructiva crónica (EPOC)]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[«EPI-Scan 2»: el primer mapa completo de la EPOC en España]]></article-title>
<source><![CDATA[Redacción Médica]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[INE: Datos de causas de muerte año 2018]]></article-title>
<source><![CDATA[Tableau Software]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="book">
<source><![CDATA[Defunciones por causas (lista reducida) por sexo y grupos de edad(7947)]]></source>
<year>2020</year>
<publisher-name><![CDATA[INE]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="">
<source><![CDATA[Importancia de los síntomas en la EPOC]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Definición, etiología, factores de riesgo y fenotipos de la EPOC]]></article-title>
<source><![CDATA[Arch Bronconeumol]]></source>
<year>2017</year>
<volume>53</volume>
<page-range>5-11</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miravitlles]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Soler-Cataluña]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Calle]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Molina]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Almagro]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Quintano]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guía española de la enfermedad pulmonar obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico en fase estable]]></article-title>
<source><![CDATA[Arch Bronconeumol]]></source>
<year>2017</year>
<volume>53</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>324-35</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alfageme]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[de Lucas]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ancochea]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Miravitlles]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Soler-Cataluña]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[García-Río]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nuevo estudio sobre la prevalencia de la EPOC en España: resumen del protocolo EPISCAN II, 10 años después de EPISCAN]]></article-title>
<source><![CDATA[Archivos de Bronconeumología]]></source>
<year>2019</year>
<volume>55</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>38-47</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Almagro]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Diez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Boixeda]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso Ortiz]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Murio]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study]]></article-title>
<source><![CDATA[Chest]]></source>
<year>2012</year>
<volume>142</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1126-33</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boixeda]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Díez-Manglano]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez-Antúnez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[López-García]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Recio]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Almagro]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consensus for managing patients with chronic obstructive pulmonary disease according to the CODEX index]]></article-title>
<source><![CDATA[Rev Clin Esp]]></source>
<year>2019</year>
<volume>219</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>494-504</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[de Miguel Díez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[TG]]></given-names>
</name>
<name>
<surname><![CDATA[Maestu]]></surname>
<given-names><![CDATA[LP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[(Comorbidities in COPD)]]></article-title>
<source><![CDATA[Arch Bronconeumol]]></source>
<year>2010</year>
<volume>46</volume>
<numero>Suppl 11</numero>
<issue>Suppl 11</issue>
<page-range>20-5</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rabinovich]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[MacNee]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic obstructive pulmonary disease and its comorbidities]]></article-title>
<source><![CDATA[Br J Hosp Med (Lond)]]></source>
<year></year>
<volume>72</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>137-45</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díez Manglano]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bernabeu-Wittel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Escalera-Zalvide]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Ledesma]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mora-Rufete]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Nieto-Martín]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comorbilidad, discapacidad y mortalidad en pacientes pluripatológicos con enfermedad pulmonar obstructiva crónica]]></article-title>
<source><![CDATA[Revista Clínica Española]]></source>
<year>2011</year>
<volume>211</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>504-10</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díez-Manglano]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Recio Iglesias]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Varela Aguilar]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Almagro Mena]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Zubillaga Garmendia]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effectiveness of a simple intervention on management of acute exacerbations of chronic obstructive pulmonary disease and its cardiovascular comorbidities: COREPOC study]]></article-title>
<source><![CDATA[Med Clin (Barc)]]></source>
<year>2017</year>
<volume>149</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>240-7</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leone]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Courbon]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Bean]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Jégo]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Leynaert]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lung function impairment and metabolic syndrome: the critical role of abdominal obesity]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2009</year>
<volume>179</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>509-16</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Luis]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comorbilidades de la enfermedad pulmonar obstructiva crónica]]></article-title>
<source><![CDATA[Arch Bronconeumol]]></source>
<year>2016</year>
<volume>52</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>547-8</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chatila]]></surname>
<given-names><![CDATA[WM]]></given-names>
</name>
<name>
<surname><![CDATA[Thomashow]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
<name>
<surname><![CDATA[Minai]]></surname>
<given-names><![CDATA[OA]]></given-names>
</name>
<name>
<surname><![CDATA[Criner]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
<name>
<surname><![CDATA[Make]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comorbidities in chronic obstructive pulmonary disease]]></article-title>
<source><![CDATA[Proc Am Thorac Soc]]></source>
<year>2008</year>
<volume>5</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>549-55</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carrasco Sánchez]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Iglesias]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Amorós]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tratamiento complementario de la insuficiencia cardíaca aguda en el paciente con diabetes, enfermedad pulmonar obstructiva crónica o anemia]]></article-title>
<source><![CDATA[Medicina Clínica]]></source>
<year>2014</year>
<volume>142</volume>
<page-range>59-65</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[ARC]]></given-names>
</name>
<name>
<surname><![CDATA[Donaldson]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Mackay]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Wedzicha]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Hurst]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD]]></article-title>
<source><![CDATA[Chest]]></source>
<year>2012</year>
<volume>141</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>851-7</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Portillo Carroz]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La anemia en la EPOC. ¿Debemos pensar en ello?]]></article-title>
<source><![CDATA[Arch Bronconeumol]]></source>
<year>2007</year>
<volume>43</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>392-8</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Hacia un tratamiento individualizado e integrado del paciente con EPOC]]></article-title>
<source><![CDATA[Archivos de Bronconeumología]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[EPOC y alteraciones endocrinometabólicas]]></article-title>
<source><![CDATA[Archivos de Bronconeumología]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[EPOC e inflamación sistémica. Una vía de enlace para la comorbilidad]]></article-title>
<source><![CDATA[Archivos de Bronconeumología]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Núñez]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Sauleda]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia-Aymerich]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Noguera]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Monsó]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ausencia de correlación entre marcadores de inflamación pulmonar y sistémica en pacientes con enfermedad pulmonar obstructiva crónica: un análisis bi-compartimental simultáneo]]></article-title>
<source><![CDATA[Arch Bronconeumol.]]></source>
<year>2016</year>
<volume>52</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>361-7</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calle Rubio]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Hermosa]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Soler-Cataluña]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[López-Campos]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Alcazar Navarrete]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Soriano]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Atención médica según el nivel de riesgo y su adecuación a las recomendaciones de la guía española de la enfermedad pulmonar obstructiva crónica (EPOC) (GesEPOC): Estudio EPOCONSUL]]></article-title>
<source><![CDATA[Arch Bronconeumol]]></source>
<year>2018</year>
<volume>54</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>270-9</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Llauger Roselló]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Pou]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Domínguez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Freixas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Valverde]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Valero]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Atención a la EPOC en el abordaje al paciente crónico en atención primaria]]></article-title>
<source><![CDATA[Arch Bronconeumol]]></source>
<year>2011</year>
<volume>47</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>561-70</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cataluña]]></surname>
<given-names><![CDATA[JJS]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[MÁM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comorbilidad cardiovascular en la EPOC]]></article-title>
<source><![CDATA[Arch Bronconeumol]]></source>
<year>2009</year>
<volume>45</volume>
<page-range>18-23</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Divo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cote]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[de Torres]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Casanova]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Marin]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Pinto-Plata]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2012</year>
<volume>186</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>155-61</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pm]]></surname>
<given-names><![CDATA[Calverley]]></given-names>
</name>
<name>
<surname><![CDATA[Ja]]></surname>
<given-names><![CDATA[Anderson]]></given-names>
</name>
<name>
<surname><![CDATA[Celli]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Ferguson]]></surname>
<given-names><![CDATA[GT]]></given-names>
</name>
<name>
<surname><![CDATA[Jenkins]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[PW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Salmeterol y propionato de fluticasona y supervivencia en la enfermedad pulmonar obstructiva crónica]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2007</year>
<volume>356</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>775-89</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rabinovich]]></surname>
<given-names><![CDATA[Roberto A]]></given-names>
</name>
<name>
<surname><![CDATA[Louvaris]]></surname>
<given-names><![CDATA[Zafeiris]]></given-names>
</name>
<name>
<surname><![CDATA[Raste]]></surname>
<given-names><![CDATA[Yogini]]></given-names>
</name>
<name>
<surname><![CDATA[Langer]]></surname>
<given-names><![CDATA[Daniel]]></given-names>
</name>
<name>
<surname><![CDATA[Van Remoortel]]></surname>
<given-names><![CDATA[Hans]]></given-names>
</name>
<name>
<surname><![CDATA[Giavedoni]]></surname>
<given-names><![CDATA[Santiago]]></given-names>
</name>
<name>
<surname><![CDATA[Burtin]]></surname>
<given-names><![CDATA[Chris]]></given-names>
</name>
<name>
<surname><![CDATA[Regueiro]]></surname>
<given-names><![CDATA[Eloisa MG]]></given-names>
</name>
<name>
<surname><![CDATA[Vogiatzis]]></surname>
<given-names><![CDATA[Ioannis]]></given-names>
</name>
<name>
<surname><![CDATA[Hopkinson]]></surname>
<given-names><![CDATA[Nicholas S]]></given-names>
</name>
<name>
<surname><![CDATA[Polkey]]></surname>
<given-names><![CDATA[Michael I]]></given-names>
</name>
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[Frederick J]]></given-names>
</name>
<name>
<surname><![CDATA[MacNee]]></surname>
<given-names><![CDATA[William]]></given-names>
</name>
<name>
<surname><![CDATA[Westerterp]]></surname>
<given-names><![CDATA[Klaas R]]></given-names>
</name>
<name>
<surname><![CDATA[Troosters]]></surname>
<given-names><![CDATA[Thierry]]></given-names>
</name>
</person-group>
<collab>consorcio PROactive</collab>
<article-title xml:lang=""><![CDATA[Westerterp, Thierry Troosters en nombre del consorcio PROactive. Validez de los monitores de actividad física durante la vida diaria en pacientes con EPOC]]></article-title>
<source><![CDATA[European Respiratory Journal]]></source>
<year>2013</year>
<volume>42</volume>
<page-range>1205-15</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bartolomé]]></surname>
<given-names><![CDATA[RCi]]></given-names>
</name>
<name>
<surname><![CDATA[Agustí]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[EPOC: ¿hora de mejorar su taxonomía?]]></article-title>
<source><![CDATA[ERJ Open Research]]></source>
<year>2018</year>
<volume>4</volume>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
